Setmelanotide is an active pharmaceutical ingredient used in the manufacture of medications for genetic obesity caused by a rare single-gene mutation. It is a peptide-based compound with high polarity and multiple amide and amine functional groups, reflecting its specialized structural character.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Setmelanotide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Setmelanotide acetate
pharmaceutical raw material
MT-II
pharmaceutical raw material
Resmetirom
pharmaceutical raw material
Fosphenytoin sodium
pharmaceutical raw material
Phosphocreatine sodium
pharmaceutical raw material
(3R)-3-Methylpiperazin-2-one
pharmaceutical raw material
The international HS code for Setmelanotide (CAS 920014-72-8) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(4R,7S,10S,13R,16S,19R,22R)-22-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carboxamide
HDHDTKMUACZDAA-PHNIDTBTSA-N
C[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5
Sourcing Setmelanotide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.